<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Biyokimya Derlemeleri &#8211; mikrobik.net</title>
	<atom:link href="https://wp.mikrobik.net/category/biyokimya/biyokimya-derlemeleri/feed/" rel="self" type="application/rss+xml" />
	<link>https://wp.mikrobik.net</link>
	<description></description>
	<lastBuildDate>Mon, 19 Jan 2026 08:26:59 +0000</lastBuildDate>
	<language>tr</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.1</generator>
	<item>
		<title>Renal Physiology</title>
		<link>https://wp.mikrobik.net/renal-physiology/</link>
					<comments>https://wp.mikrobik.net/renal-physiology/#respond</comments>
		
		<dc:creator><![CDATA[mikrobik]]></dc:creator>
		<pubDate>Thu, 25 Dec 2025 14:36:00 +0000</pubDate>
				<category><![CDATA[Biyokimya Derlemeleri]]></category>
		<category><![CDATA[GFR]]></category>
		<category><![CDATA[kidney]]></category>
		<guid isPermaLink="false">https://wp.mikrobik.net/?p=3063</guid>

					<description><![CDATA[Renal PhysiologyIfeanyichukwu Ogobuiro; Faiz Tuma. Tam metin için tıklayınız The renal system consists of the kidney, ureters, and the urethra. The overall function of the system filters approximately 200 liters of fluid a...]]></description>
										<content:encoded><![CDATA[
<p><strong><span style="color:#5C3566;">Renal Physiology</span></strong><br>Ifeanyichukwu Ogobuiro; Faiz Tuma.</p>



<p>Tam metin için <a href="https://www.ncbi.nlm.nih.gov/books/NBK538339/" target="_blank" rel="noopener">tıklayınız</a></p>



<p>The renal system consists of the kidney, ureters, and the urethra. The overall function of the system filters approximately 200 liters of fluid a day from renal blood flow which allows for toxins, metabolic waste products, and excess ion to be excreted while keeping essential substances in the blood. The kidney regulates plasma osmolarity by modulating the amount of water, solutes, and electrolytes in the blood. It ensures long term acid-base balance and also produces erythropoietin which stimulates the production of red blood cell. It also produces renin for blood pressure regulation and carries out the conversion of vitamin D to its active form. The renal development, the process of urine production and excretion, and the clinical significance of the renal system will be the focus of this article.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://wp.mikrobik.net/renal-physiology/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Critical Issues and New Trends on Stat Tests in Clinical Laboratory</title>
		<link>https://wp.mikrobik.net/critical-issues-and-new-trends-on-stat-tests-in-clinical-laboratory/</link>
					<comments>https://wp.mikrobik.net/critical-issues-and-new-trends-on-stat-tests-in-clinical-laboratory/#respond</comments>
		
		<dc:creator><![CDATA[mikrobik]]></dc:creator>
		<pubDate>Tue, 16 Dec 2025 14:38:00 +0000</pubDate>
				<category><![CDATA[Biyokimya Derlemeleri]]></category>
		<category><![CDATA[clinical laboratory]]></category>
		<category><![CDATA[stat tests]]></category>
		<category><![CDATA[symposium]]></category>
		<guid isPermaLink="false">https://wp.mikrobik.net/?p=3069</guid>

					<description><![CDATA[Critical Issues and New Trends on Stat Tests in Clinical LaboratoryAriadna Arbiol-Roca 1,✉, Dolors Dot-Bach EJIFCC. 2019 Mar 1;30(1):59–66. Meeting Report on the IX European Symposium on Clinical Laboratory and In Vitro Diagnostics...]]></description>
										<content:encoded><![CDATA[
<p><strong><span style="color:#5C3566;">Critical Issues and New Trends on Stat Tests in Clinical Laboratory</span></strong><br>Ariadna Arbiol-Roca 1,<img src="https://s.w.org/images/core/emoji/17.0.2/72x72/2709.png" alt="✉" class="wp-smiley" style="height: 1em; max-height: 1em;" />, Dolors Dot-Bach</p>



<p>EJIFCC. 2019 Mar 1;30(1):<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6416811/pdf/ejifcc-30-059.pdf" target="_blank" rel="noopener">59–66.</a></p>



<p>Meeting Report on the IX European Symposium on Clinical Laboratory and In Vitro Diagnostics Industry (Barcelona)<br>The IX European Symposium of the Clinical Laboratory and In Vitro Diagnostics Industry, entitled “Stat Tests in Clinical laboratory”, took place in Barcelona, Catalonia (Spain), between May 17–18, 2017.</p>



<p>The scientific program was structured in several round-tables that dealt with the following topics: emergency laboratory models, accreditation of stat tests by ISO 15189, critical issues of stat tests and the new proposals of the in vitro diagnostics industry for emergency laboratories. The aim of the Symposium was the discussion of the transformation that stat tests have generated on clinical laboratories in terms of organization, turnaround time, accreditation, and probable evolution of these laboratories coming years.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://wp.mikrobik.net/critical-issues-and-new-trends-on-stat-tests-in-clinical-laboratory/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Kidney and blood pressure regulation—latest evidence for molecular mechanisms</title>
		<link>https://wp.mikrobik.net/kidney-and-blood-pressure-regulation-latest-evidence-for-molecular-mechanisms/</link>
					<comments>https://wp.mikrobik.net/kidney-and-blood-pressure-regulation-latest-evidence-for-molecular-mechanisms/#respond</comments>
		
		<dc:creator><![CDATA[mikrobik]]></dc:creator>
		<pubDate>Tue, 16 Dec 2025 14:37:00 +0000</pubDate>
				<category><![CDATA[Biyokimya Derlemeleri]]></category>
		<category><![CDATA[blood pressure regulation]]></category>
		<category><![CDATA[hypertension]]></category>
		<category><![CDATA[renal salt transport]]></category>
		<category><![CDATA[renin–angiotensin–aldosterone system (raas)]]></category>
		<guid isPermaLink="false">https://wp.mikrobik.net/?p=3067</guid>

					<description><![CDATA[Kidney and blood pressure regulation—latest evidence for molecular mechanismsYoko Suzumoto 1,✉, Laura Zucaro 2,3, Anna Iervolino 4,5, Giovambattista Capasso Clin Kidney J. 2023 Jan 24;16(6):952–964 Hypertension is one of the major health problems...]]></description>
										<content:encoded><![CDATA[
<p><strong><span style="color:#5C3566;">Kidney and blood pressure regulation—latest evidence for molecular mechanisms</span></strong><br>Yoko Suzumoto 1,<img src="https://s.w.org/images/core/emoji/17.0.2/72x72/2709.png" alt="✉" class="wp-smiley" style="height: 1em; max-height: 1em;" />, Laura Zucaro 2,3, Anna Iervolino 4,5, Giovambattista Capasso</p>



<p>Clin Kidney J. 2023 Jan 24;16(6):<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10229285/pdf/sfad015.pdf" target="_blank" rel="noopener">952–964</a></p>



<p>Hypertension is one of the major health problems leading to the development of cardiovascular diseases. Despite a rapid expansion in global hypertension prevalence, molecular mechanisms leading to hypertension are not fully understood largely due to the complexity of pathogenesis involving several factors. Salt intake is recognized as a leading determinant of blood pressure, since reduced dietary salt intake is related to lower morbidity and mortality, and hypertension in relation to cardiovascular events. Compared with salt-resistant populations, salt-sensitive individuals exhibit high sensitivity in blood pressure responses according to changes in salt intake. In this setting, the kidney plays a major role in the maintenance of blood pressure under the hormonal control of the renin–angiotensin–aldosterone system. In the present review, we summarize the current overview on the molecular mechanisms for modulation of blood pressure associated with renal ion channels/transporters including sodium–hydrogen exchanger isoform 3 (NHE3), Na+-K+-2Cl– cotransporter (NKCC2), sodium–chloride cotransporter (NCC), epithelial sodium channel (ENaC) and pendrin expressed in different nephron segments. In particular, recent studies on experimental animal models with deletion of renal ion channels led to the identification of several crucial physiological mechanisms and molecules involved in hypertension. These findings could further provide a potential for novel therapeutic approaches applicable on human patients with hypertension.<br><img decoding="async" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be6c/10229285/af78a18091b4/sfad015fig1.jpg" alt="" style="max-width:100%;height:auto;" /><img decoding="async" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be6c/10229285/196658642123/sfad015fig3.jpg" alt="" style="max-width:100%;height:auto;" /></p>
]]></content:encoded>
					
					<wfw:commentRss>https://wp.mikrobik.net/kidney-and-blood-pressure-regulation-latest-evidence-for-molecular-mechanisms/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Collecting Duct Intercalated Cell Function and Regulation</title>
		<link>https://wp.mikrobik.net/collecting-duct-intercalated-cell-function-and-regulation/</link>
					<comments>https://wp.mikrobik.net/collecting-duct-intercalated-cell-function-and-regulation/#respond</comments>
		
		<dc:creator><![CDATA[mikrobik]]></dc:creator>
		<pubDate>Tue, 16 Dec 2025 14:36:00 +0000</pubDate>
				<category><![CDATA[Biyokimya Derlemeleri]]></category>
		<guid isPermaLink="false">https://wp.mikrobik.net/?p=3065</guid>

					<description><![CDATA[Collecting Duct Intercalated Cell Function and RegulationAnkita Roy, Mohammad M Al-bataineh, Núria M Pastor-Soler Clin J Am Soc Nephrol. 2015 Jan 28;10(2):305–324. Intercalated cells are kidney tubule epithelial cells with important roles in...]]></description>
										<content:encoded><![CDATA[
<p><strong><span style="color:#5C3566;">Collecting Duct Intercalated Cell Function and Regulation</span></strong><br>Ankita Roy, Mohammad M Al-bataineh, Núria M Pastor-Soler</p>



<p>Clin J Am Soc Nephrol. 2015 Jan 28;10(2):<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4317747/" target="_blank" rel="noopener">305–324.</a></p>



<p>Intercalated cells are kidney tubule epithelial cells with important roles in the regulation of acid-base homeostasis. However, in recent years the understanding of the function of the intercalated cell has become greatly enhanced and has shaped a new model for how the distal segments of the kidney tubule integrate salt and water reabsorption, potassium homeostasis, and acid-base status. These cells appear in the late distal convoluted tubule or in the connecting segment, depending on the species. They are most abundant in the collecting duct, where they can be detected all the way from the cortex to the initial part of the inner medulla. Intercalated cells are interspersed among the more numerous segment-specific principal cells. There are three types of intercalated cells, each having distinct structures and expressing different ensembles of transport proteins that translate into very different functions in the processing of the urine. This review includes recent findings on how intercalated cells regulate their intracellular milieu and contribute to acid-base regulation and sodium, chloride, and potassium homeostasis, thus highlighting their potential role as targets for the treatment of hypertension. Their novel regulation by paracrine signals in the collecting duct is also discussed. Finally, this article addresses their role as part of the innate immune system of the kidney tubule.</p>



<p><img decoding="async" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebf1/4317747/daf85097a73e/CJN.08880914f2.jpg" alt="" style="max-width:100%;height:auto;" /><img decoding="async" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebf1/4317747/88c6ce3369f5/CJN.08880914f6.jpg" alt="" style="max-width:100%;height:auto;" /></p>
]]></content:encoded>
					
					<wfw:commentRss>https://wp.mikrobik.net/collecting-duct-intercalated-cell-function-and-regulation/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Current use of bone turnover markers in the management of osteoporosis</title>
		<link>https://wp.mikrobik.net/current-use-of-bone-turnover-markers-in-the-management-of-osteoporosis/</link>
					<comments>https://wp.mikrobik.net/current-use-of-bone-turnover-markers-in-the-management-of-osteoporosis/#respond</comments>
		
		<dc:creator><![CDATA[mikrobik]]></dc:creator>
		<pubDate>Tue, 09 Dec 2025 14:35:00 +0000</pubDate>
				<category><![CDATA[Biyokimya Derlemeleri]]></category>
		<category><![CDATA[biochemical markers]]></category>
		<category><![CDATA[biological variability]]></category>
		<category><![CDATA[bone turnover markers]]></category>
		<category><![CDATA[c-telopeptide cross-linked type 1 collagen]]></category>
		<category><![CDATA[ct-procollagen type i n-propeptide]]></category>
		<category><![CDATA[osteoporosis]]></category>
		<category><![CDATA[pinp]]></category>
		<guid isPermaLink="false">https://wp.mikrobik.net/?p=3061</guid>

					<description><![CDATA[Current use of bone turnover markers in the management of osteoporosisJacques P. Brown, Andrew Don-Wauchope Samue D. VasikaranClinical Biochemistry 109-110 (2022) 1–10 Tam metin için tıklayınız The adult bone is continuously being remodelled...]]></description>
										<content:encoded><![CDATA[
<p><strong><span style="color:#5C3566;">Current use of bone turnover markers in the management of osteoporosi</span>s</strong><br>Jacques P. Brown, Andrew Don-Wauchope Samue D. Vasikaran<br>Clinical Biochemistry 109-110 (2022) 1–10 Tam metin için <a href="https://www.sciencedirect.com/science/article/pii/S0009912022002041/pdfft?md5=05601869c60917df155c0a9e5801c740&amp;pid=1-s2.0-S0009912022002041-main.pdf" target="_blank" rel="noopener">tıklayınız</a></p>



<p>The adult bone is continuously being remodelled to repair microdamage, preserve bone strength and mechanical competence as well as maintain calcium homeostasis. Bone turnover markers are products of osteoblasts (bone formation markers) and osteoclasts (bone resorption markers) providing a dynamic assessment of remodelling (turnover). Resorption-specific bone turnover markers are typically degradation products of bone collagen molecules (N- [NTX] and C-telopeptide cross-linked type 1 collagen [CTX]), which are released into the circulation and excreted in urine; or enzymatic activities reflecting osteoclastic resorption, tartrate-resistant acid phosphatase [TRACP]. Formation-specific bone turnover markers embrace different osteoblastic activities: type 1 collagen synthesis (Procollagen type I N- propeptide [PINP]), osteoblast enzymes (bone-specific alkaline phosphatase [BALP]), or bone matrix proteins [osteocalcin]. Among individuals not receiving osteoporosis treatment, resorption and formation markers are tightly linked and highly correlated (r = 0.6–0.8). Significant biological variability was reported in the past, but these issues have been greatly improved with automated assays and attention to pre-analytical and analytical factors that are known to influence bone turnover marker levels. Bone turnover markers are not useful in the diagnosis of osteoporosis, the individual prediction of bone loss, fracture, or rare complications, or in the selection of pharmacological treatment. Despite remaining issues with reference intervals and assays harmonization, bone turnover markers have proven to be useful in elucidating the pharmacodynamics and effectiveness of osteoporosis medications in clinical trials. As an alternative to BMD testing, BTMs may be useful to monitor osteoporosis therapies.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://wp.mikrobik.net/current-use-of-bone-turnover-markers-in-the-management-of-osteoporosis/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Red Blood Cell Metabolism In Vivo and In Vitro</title>
		<link>https://wp.mikrobik.net/red-blood-cell-metabolism-in-vivo-and-in-vitro/</link>
					<comments>https://wp.mikrobik.net/red-blood-cell-metabolism-in-vivo-and-in-vitro/#respond</comments>
		
		<dc:creator><![CDATA[mikrobik]]></dc:creator>
		<pubDate>Fri, 10 Oct 2025 14:29:00 +0000</pubDate>
				<category><![CDATA[Biyokimya Derlemeleri]]></category>
		<category><![CDATA[erythrocyte]]></category>
		<category><![CDATA[hematology]]></category>
		<category><![CDATA[hemolysis]]></category>
		<category><![CDATA[iron]]></category>
		<category><![CDATA[Mitochondria]]></category>
		<category><![CDATA[red blood cell]]></category>
		<category><![CDATA[spleen]]></category>
		<category><![CDATA[storage lesion]]></category>
		<category><![CDATA[transfusion medicine]]></category>
		<guid isPermaLink="false">https://wp.mikrobik.net/?p=3059</guid>

					<description><![CDATA[Angelo D’Alessandro, Alkmini T. Anastasiadi, Vassilis L. Tzounakas, Travis Nemkov, Julie A. Reisz, Anastsios G. Kriebardis, James C. Zimring, Steven L. Spitalnik and Michael P. Busch Metabolites 2023, 13(7), 793 Full text için...]]></description>
										<content:encoded><![CDATA[<p><strong><span style="color:#5C3566;">Red Blood Cell Metabolism In Vivo and In Vitro</span></strong></p>



<p>Angelo D’Alessandro, Alkmini T. Anastasiadi, Vassilis L. Tzounakas, Travis Nemkov, Julie A. Reisz, Anastsios G. Kriebardis, James C. Zimring, Steven L. Spitalnik and Michael P. Busch</p>



<p>Metabolites 2023, 13(7), 793 Full text için <a href="https://www.mdpi.com/2218-1989/13/7/793/pdf" target="_blank" rel="noopener">tıklayınız</a></p>



<p>Red blood cells (RBC) are the most abundant cell in the human body, with a central role in oxygen transport and its delivery to tissues. However, omics technologies recently revealed the unanticipated complexity of the RBC proteome and metabolome, paving the way for a reinterpretation of the mechanisms by which RBC metabolism regulates systems biology beyond oxygen transport. The new data and analytical tools also informed the dissection of the changes that RBCs undergo during refrigerated storage under blood bank conditions, a logistic necessity that makes &gt;100 million units available for life-saving transfusions every year worldwide. In this narrative review, we summarize the last decade of advances in the field of RBC metabolism in vivo and in the blood bank in vitro, a narrative largely influenced by the authors’ own journeys in this field. We hope that this review will stimulate further research in this interesting and medically important area or, at least, serve as a testament to our fascination with this simple, yet complex, cell.</p>


<p><img decoding="async" src="https://mdpi-res.com/metabolites/metabolites-13-00793/article_deploy/html/images/metabolites-13-00793-g001-550.jpg" alt="" style="max-width:100%;height:auto;" /></p>
]]></content:encoded>
					
					<wfw:commentRss>https://wp.mikrobik.net/red-blood-cell-metabolism-in-vivo-and-in-vitro/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Inherited disorders of bilirubin clearance</title>
		<link>https://wp.mikrobik.net/inherited-disorders-of-bilirubin-clearance/</link>
					<comments>https://wp.mikrobik.net/inherited-disorders-of-bilirubin-clearance/#respond</comments>
		
		<dc:creator><![CDATA[mikrobik]]></dc:creator>
		<pubDate>Wed, 08 Oct 2025 14:21:00 +0000</pubDate>
				<category><![CDATA[Biyokimya]]></category>
		<category><![CDATA[Biyokimya Derlemeleri]]></category>
		<category><![CDATA[bilirubin]]></category>
		<category><![CDATA[conjugation]]></category>
		<category><![CDATA[icterus]]></category>
		<category><![CDATA[sarılık]]></category>
		<guid isPermaLink="false">https://wp.mikrobik.net/?p=3055</guid>

					<description><![CDATA[Inherited disorders of bilirubin clearanceNaureen Memon, Barry I Weinberger, Thomas Hegyi &#38; Lauren M AleksunesPediatric Research volume 79, pages378–386 nherited disorders of hyperbilirubinemia may be caused by increased bilirubin production or decreased bilirubin...]]></description>
										<content:encoded><![CDATA[
<p><strong><span style="color:#5C3566;">Inherited disorders of bilirubin clearance</span></strong><br>Naureen Memon, Barry I Weinberger, Thomas Hegyi &amp; Lauren M Aleksunes<br>Pediatric Research <a href="https://www.nature.com/articles/pr2015247.pdf" target="_blank" rel="noopener">volume 79, pages378–386</a></p>



<p>nherited disorders of hyperbilirubinemia may be caused by increased bilirubin production or decreased bilirubin clearance. Reduced hepatic bilirubin clearance can be due to defective (i) unconjugated bilirubin uptake and intrahepatic storage, (ii) conjugation of glucuronic acid to bilirubin (e.g., Gilbert syndrome, Crigler–Najjar syndrome, Lucey–Driscoll syndrome, breast milk jaundice), (iii) bilirubin excretion into bile (Dubin–Johnson syndrome), or (iv) conjugated bilirubin re-uptake (Rotor syndrome). In this review, the molecular mechanisms and clinical manifestations of these conditions are described, as well as current approaches to diagnosis and therapy.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://wp.mikrobik.net/inherited-disorders-of-bilirubin-clearance/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Canlıların Biyokimyasal Özellikleri</title>
		<link>https://wp.mikrobik.net/canlilarin-biyokimyasal-ozellikleri/</link>
		
		<dc:creator><![CDATA[mikrobik]]></dc:creator>
		<pubDate>Sun, 22 Jun 2025 13:32:51 +0000</pubDate>
				<category><![CDATA[Biyokimya Derlemeleri]]></category>
		<category><![CDATA[biyokimya]]></category>
		<category><![CDATA[kimyasal yapı]]></category>
		<guid isPermaLink="false">https://wp.mikrobik.net/?p=7</guid>

					<description><![CDATA["Canlı organizmalar, cansız moleküllerden oluşmuşlardır. Bu moleküllerin, cansız maddelerin uymak zorunda oldukları tüm fiziksel ve kimyasal kurallara uydukları görülür. Ancak yaşayan organizmalar, cansız madde topluluklarının sahip olmadıkları üstün özelliklere sahiptir. İşte bu özellikleri incelemek ve nedenlerini araştırmak biyokimya ilminin konusudur. Biyokimyager ise, canlıların kimyasal yapı ve davranışlarını, kimyasal, fiziksel ve biyolojik yöntemler kullanarak araştıran bir bilim adamıdır."]]></description>
										<content:encoded><![CDATA[
<p><strong>Canlıların Biyokimyasal Özellikleri</strong><br>Prof. Dr. T. Aslan AKSU</p>



<p><a target="_blank" href="http://www.mikrobik.net/datas/users/1-cantemel.pdf" rel="noreferrer noopener">Tam metin için tıklayınız</a></p>



<p>&#8220;Canlı organizmalar, cansız moleküllerden oluşmuşlardır. Bu moleküllerin, cansız maddelerin uymak zorunda oldukları tüm fiziksel ve kimyasal kurallara uydukları görülür. Ancak yaşayan organizmalar, cansız madde topluluklarının sahip olmadıkları üstün özelliklere sahiptir. İşte bu özellikleri incelemek ve nedenlerini araştırmak biyokimya ilminin konusudur. Biyokimyager ise, canlıların kimyasal yapı ve davranışlarını, kimyasal, fiziksel ve biyolojik yöntemler kullanarak araştıran bir bilim adamıdır.&#8221;</p>



<p></p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Yapay Zeka Araçlarının Eğitimde Kullanılmasına İlişkin Durum Raporu ve Öneriler</title>
		<link>https://wp.mikrobik.net/yapay-zeka-araclarinin-egitmde-kullanilmasina-iliskin-durum-raporu-ve-oneriler/</link>
					<comments>https://wp.mikrobik.net/yapay-zeka-araclarinin-egitmde-kullanilmasina-iliskin-durum-raporu-ve-oneriler/#respond</comments>
		
		<dc:creator><![CDATA[mikrobik]]></dc:creator>
		<pubDate>Wed, 11 Jun 2025 11:46:00 +0000</pubDate>
				<category><![CDATA[Biyokimya Derlemeleri]]></category>
		<category><![CDATA[yapay zeka]]></category>
		<guid isPermaLink="false"></guid>

					<description><![CDATA[Ferhan G. Sağın ve Ali Burak Özkaya Funda Tengiz Öykü Gönül Geyik Caner Geyik TBD Akademi Tam metin için tıklayınız Türk Biyokimya Derneği (TBD) Akademi olarak, yukarıda verilen bilgilerin ışığında ve devam eden...]]></description>
										<content:encoded><![CDATA[<p>Ferhan G. Sağın ve Ali Burak Özkaya Funda Tengiz Öykü Gönül Geyik Caner Geyik<br />
TBD Akademi</p>
<p>Tam metin için <a href="https://yonetim.citius.technology/files/kurum/kurum78/haber/tbd-akademi-eg-itim-grubu&#8212;yapay-zeka-arac-larinin-eg-itimde-kullanilmasina-i-lis-kin-durum-raporu-ve-o-neriler.pdf" target="_blank" rel="noopener">tıklayınız</a></p>
<p>Türk Biyokimya Derneği (TBD) Akademi olarak, yukarıda verilen bilgilerin ışığında ve devam eden tartışmaları dışlamadan, tüm meslektaşlarımızın ve eğiticilerin YZ okuryazarı olmalarını ve alanla ilgili bazı yetkinlikleri kazanmalarını önemsiyoruz. Bu belge de, eğiticilere bu yeni mecra konusunda farkındalık sağlamak ve YZ araçlarının eğitim ve öğrenmeyi iyileştirmek amacıyla nasıl kullanılabileceği konusunda temel bazı örnekler sunmak için hazırlanmış r. Bununla birlikte çok hızlı gelişen bir alan olması nedeniyle, tüm eği cilerin güncellemeleri ve alanla ilgili değişimleri yakından takip etmelerini de öneriyoruz. Bu belgenin en yaygın kullanılan üretici YZ araçlarının başında gelen ChatGPT&#8217;nin son ücretsiz sürümü olan GPT-3.5&#8217;i temel aldığı göz önünde bulundurulmalıdır. Ana amaçlarımızdan biri de 2023-2024 akademik yılı başında bu konuya dikkat çekmek ve eği cilere ders yılı başında ve sonrasında uygulayabilecekleri bazı önerilerde bulunarak bir yol haritası sunmaktır.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://wp.mikrobik.net/yapay-zeka-araclarinin-egitmde-kullanilmasina-iliskin-durum-raporu-ve-oneriler/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>A review on laboratory liver function tests.</title>
		<link>https://wp.mikrobik.net/a-review-on-laboratory-liver-function-tests/</link>
		
		<dc:creator><![CDATA[mikrobik]]></dc:creator>
		<pubDate>Tue, 06 May 2025 14:42:00 +0000</pubDate>
				<category><![CDATA[Biyokimya Derlemeleri]]></category>
		<category><![CDATA[LFT]]></category>
		<category><![CDATA[liver]]></category>
		<guid isPermaLink="false"></guid>

					<description><![CDATA[Gowda S, Desai PB, Hull VV, Math AA, Vernekar SN, Kulkarni SS. Pan Afr Med J. 2009 Nov 22;3:17. Laboratory liver tests are broadly defined as tests useful in the evaluation and treatment...]]></description>
										<content:encoded><![CDATA[<p>Gowda S, Desai PB, Hull VV, Math AA, Vernekar SN, Kulkarni SS. <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2984286/pdf/pamj-03-17.pdf" target="_blank" rel="noopener">Pan Afr Med J. 2009 Nov 22;3:17.</a></p>
<p>Laboratory liver tests are broadly defined as tests useful in the evaluation and treatment of patients with hepatic dysfunction. The liver carries out metabolism of carbohydrate, protein and fats. Some of the enzymes and the end products of the metabolic pathway which are very sensitive for the abnormality occurred may be considered as biochemical marker of liver dysfunction. Some of the biochemical markers such as serum bilirubin, alanine amino transferase, aspartate amino transferase, ratio of aminotransferases, alkaline phosphatase, gamma glutamyl transferase, 5′ nucleotidase, ceruloplasmin, α-fetoprotein are considered in this article. An isolated or conjugated alteration of biochemical markers of liver damage in patients can challenge the clinicians during the diagnosis of disease related to liver directly or with some other organs. The term “liver chemistry tests” is a frequently used but poorly defined phrase that encompasses the numerous serum chemistries that can be assayed to assess hepatic function and/or injury.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Pathophysiology of Atherosclerosis</title>
		<link>https://wp.mikrobik.net/pathophysiology-of-atherosclerosis/</link>
		
		<dc:creator><![CDATA[mikrobik]]></dc:creator>
		<pubDate>Mon, 06 Jan 2025 15:39:03 +0000</pubDate>
				<category><![CDATA[Biyokimya Derlemeleri]]></category>
		<category><![CDATA[atherosclerosis]]></category>
		<guid isPermaLink="false"></guid>

					<description><![CDATA[Jebari-Benslaiman S, Galicia-García U, Larrea-Sebal A, Olaetxea JR, Alloza I, Vandenbroeck K, Benito-Vicente A, Martín C. .
Int J Mol Sci. 2022 Mar]]></description>
										<content:encoded><![CDATA[<p><strong><span style="color:#5C3566;">Pathophysiology of Atherosclerosis</span></strong><br />
Jebari-Benslaiman S, Galicia-García U, Larrea-Sebal A, Olaetxea JR, Alloza I, Vandenbroeck K, Benito-Vicente A, Martín C. .<br />
Int J Mol Sci. 2022 Mar <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8954705/pdf/ijms-23-03346.pdf" target="_blank" rel="noopener">20;23(6):3346.</a></p>
<p>Atherosclerosis is the main risk factor for cardiovascular disease (CVD), which is the leading cause of mortality worldwide. Atherosclerosis is initiated by endothelium activation and, followed by a cascade of events (accumulation of lipids, fibrous elements, and calcification), triggers the vessel narrowing and activation of inflammatory pathways. The resultant atheroma plaque, along with these processes, results in cardiovascular complications. This review focuses on the different stages of atherosclerosis development, ranging from endothelial dysfunction to plaque rupture. In addition, the post-transcriptional regulation and modulation of atheroma plaque by microRNAs and lncRNAs, the role of microbiota, and the importance of sex as a crucial risk factor in atherosclerosis are covered here in order to provide a global view of the disease.<br />
<img decoding="async" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50b6/8954705/d9839d921ea0/ijms-23-03346-g001.jpg" alt="" style="max-width:100%;height:auto;" /></p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Inflammation in atherosclerosis: pathophysiology and mechanisms</title>
		<link>https://wp.mikrobik.net/inflammation-in-atherosclerosis-pathophysiology-and-mechanisms/</link>
		
		<dc:creator><![CDATA[mikrobik]]></dc:creator>
		<pubDate>Mon, 06 Jan 2025 15:34:00 +0000</pubDate>
				<category><![CDATA[Biyokimya Derlemeleri]]></category>
		<category><![CDATA[atherosclerosis]]></category>
		<category><![CDATA[inflammation]]></category>
		<guid isPermaLink="false"></guid>

					<description><![CDATA[Ajoolabady, A., Pratico, D., Lin, L. et al. Cell Death Dis 15, 817 (2024). Atherosclerosis imposes a heavy burden on cardiovascular health due to its indispensable role in the pathogenesis of cardiovascular disease...]]></description>
										<content:encoded><![CDATA[<p>Ajoolabady, A., Pratico, D., Lin, L. et al.<br />
Cell Death Dis <a href="https://www.nature.com/articles/s41419-024-07166-8.pdf" target="_blank" rel="noopener">15, 817 (2024)</a>.</p>
<p>Atherosclerosis imposes a heavy burden on cardiovascular health due to its indispensable role in the pathogenesis of cardiovascular disease (CVD) such as coronary artery disease and heart failure. Ample clinical and experimental evidence has corroborated the vital role of inflammation in the pathophysiology of atherosclerosis. Hence, the demand for preclinical research into atherosclerotic inflammation is on the horizon. Indeed, the acquisition of an in-depth knowledge of the molecular and cellular mechanisms of inflammation in atherosclerosis should allow us to identify novel therapeutic targets with translational merits. In this review, we aimed to critically discuss and speculate on the recently identified molecular and cellular mechanisms of inflammation in atherosclerosis. Moreover, we delineated various signaling cascades and proinflammatory responses in macrophages and other leukocytes that promote plaque inflammation and atherosclerosis. In the end, we highlighted potential therapeutic targets, the pros and cons of current interventions, as well as anti-inflammatory and atheroprotective mechanisms.</p>
]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>
